Bo Dong Selected Research

poly-gamma-benzyl-L-glutamate

1/2018	In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles.
1/2017	Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Dong Research Topics

Disease

21	Neoplasms (Cancer) 04/2022 - 07/2010
12	Inflammation (Inflammations) 05/2022 - 09/2008
12	Infections 01/2022 - 11/2005
11	Atherosclerosis 01/2022 - 04/2005
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2015
8	Fibrosis (Cirrhosis) 01/2021 - 11/2010
7	Glioma (Gliomas) 03/2022 - 07/2010
7	Diabetic Cardiomyopathies 01/2021 - 02/2012
6	Myocardial Infarction 03/2021 - 11/2010
6	Abdominal Aortic Aneurysm 01/2020 - 01/2014
6	Atherosclerotic Plaque (Atheroma) 08/2017 - 07/2008
5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2016
5	Reperfusion Injury 10/2018 - 01/2017
4	Adenocarcinoma of Lung 10/2021 - 01/2021
4	Hemorrhage 08/2021 - 03/2001
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2018
3	Hypoxia (Hypoxemia) 05/2022 - 10/2018
3	Necrosis 01/2022 - 12/2006
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 02/2017
3	Wounds and Injuries (Trauma) 12/2020 - 03/2007
3	Ischemia 08/2020 - 01/2017
3	Hematoma 01/2019 - 12/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2017 - 07/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 04/2013
3	Thrombocytopenia (Thrombopenia) 08/2004 - 06/2000
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022 - 01/2011
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 04/2017
2	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 08/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2019
2	Pathologic Processes 01/2021 - 07/2018
2	Pain (Aches) 12/2020 - 10/2020
2	Starvation 08/2020 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 01/2019
2	Alcoholic Cardiomyopathy 11/2019 - 01/2019
2	Sleep Wake Disorders 01/2019 - 01/2016
2	Neointima 10/2018 - 04/2005
2	Hyperplasia 10/2018 - 10/2018
2	Coronary Disease (Coronary Heart Disease) 10/2018 - 01/2014
2	Hyperglycemia 10/2016 - 02/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 11/2007
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2005
13	Messenger RNA (mRNA)IBA 03/2022 - 04/2005
10	Long Noncoding RNAIBA 03/2021 - 04/2017
9	Angiotensin IIIBA 01/2020 - 07/2008
7	Biological ProductsIBA 04/2022 - 09/2008
7	Prorenin ReceptorIBA 01/2021 - 01/2019
6	MicroRNAs (MicroRNA)IBA 12/2021 - 06/2014
6	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2017
5	CollagenIBA 01/2022 - 11/2010
5	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2019
5	Angiotensin-Converting Enzyme 2IBA 12/2018 - 07/2009
4	RNA (Ribonucleic Acid)IBA 03/2022 - 04/2017
4	oxidized low density lipoproteinIBA 01/2022 - 04/2005
4	EnzymesIBA 01/2021 - 02/2012
4	angiotensin I (1-7)IBA 01/2020 - 07/2008
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2007
4	ApolipoproteinsIBA 01/2020 - 10/2018
4	CholesterolIBA 06/2015 - 04/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022 - 11/2007
3	Pharmaceutical PreparationsIBA 04/2022 - 02/2018
3	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
3	Therapeutic UsesIBA 10/2021 - 06/2000
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 02/2017
3	CateninsIBA 08/2020 - 04/2017
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2006
3	InflammasomesIBA 01/2020 - 07/2017
3	Cyclin D1IBA 09/2010 - 03/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2022 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 04/2022 - 11/2007
2	OsteopontinIBA 03/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	Complementary DNA (cDNA)IBA 01/2022 - 09/2006
2	LipopolysaccharidesIBA 11/2021 - 01/2020
2	Alanine Transaminase (SGPT)IBA 05/2021 - 12/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 03/2011
2	Substance PIBA 10/2020 - 01/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2020 - 01/2020
2	Rosuvastatin Calcium (Crestor)FDA Link 08/2020 - 10/2018
2	Coloring Agents (Dyes)IBA 07/2020 - 09/2014
2	AVE 0991IBA 01/2020 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2019 - 04/2013
2	poly-gamma-benzyl-L-glutamateIBA 01/2018 - 01/2017
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018 - 01/2017
2	CurcuminIBA 01/2018 - 01/2014
2	CytokinesIBA 10/2017 - 01/2004
2	AntigensIBA 08/2017 - 10/2004
2	oil red OIBA 06/2015 - 12/2014
2	Losartan (Cozaar)FDA LinkGeneric 06/2015 - 10/2011

Therapy/Procedure

9	Therapeutics 10/2021 - 01/2004
5	Electroacupuncture 10/2020 - 01/2016
4	Drug Therapy (Chemotherapy) 10/2021 - 06/2000
3	Catheters 01/2019 - 10/2018
2	Radiotherapy 01/2020 - 07/2010
2	Minimally Invasive Surgical Procedures 01/2019 - 10/2018
2	Craniotomy 01/2019 - 10/2018